| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,370 |
16,461 |
$2.03M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,116 |
14,178 |
$2.02M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,526 |
4,280 |
$1.15M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,776 |
5,006 |
$736K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,302 |
1,512 |
$701K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
8,479 |
2,912 |
$598K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,120 |
1,686 |
$543K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
5,512 |
1,806 |
$462K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,791 |
1,452 |
$416K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,916 |
1,308 |
$338K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,895 |
2,654 |
$312K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,321 |
2,024 |
$270K |
| 97803 |
|
2,433 |
2,183 |
$212K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,997 |
1,761 |
$207K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,518 |
4,043 |
$177K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
732 |
503 |
$144K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
572 |
428 |
$134K |
| 64483 |
|
205 |
171 |
$128K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,060 |
883 |
$114K |
| G0378 |
Hospital observation service, per hour |
1,816 |
780 |
$109K |
| 80053 |
Comprehensive metabolic panel |
5,928 |
4,915 |
$107K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,863 |
2,573 |
$101K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
892 |
533 |
$92K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,777 |
2,491 |
$65K |
| 74246 |
|
426 |
392 |
$64K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
15,289 |
12,001 |
$62K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,976 |
1,662 |
$61K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
27,764 |
22,231 |
$60K |
| 97161 |
|
864 |
724 |
$58K |
| 71046 |
Radiologic examination, chest; 2 views |
3,198 |
2,921 |
$57K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
274 |
215 |
$54K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,989 |
3,548 |
$53K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
531 |
464 |
$50K |
| 36415 |
Collection of venous blood by venipuncture |
23,875 |
18,891 |
$48K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
243 |
119 |
$46K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
465 |
428 |
$45K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,045 |
4,191 |
$44K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
204 |
176 |
$43K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
823 |
716 |
$41K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
51 |
39 |
$38K |
| 84439 |
|
2,300 |
2,051 |
$38K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
4,909 |
3,782 |
$34K |
| 80076 |
|
7,939 |
6,604 |
$33K |
| 80061 |
Lipid panel |
3,098 |
2,791 |
$32K |
| 82607 |
|
1,716 |
1,540 |
$32K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,475 |
2,194 |
$31K |
| 87070 |
|
1,509 |
1,300 |
$30K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
1,002 |
969 |
$29K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
713 |
639 |
$29K |
| 97802 |
|
335 |
301 |
$29K |
| 81513 |
|
239 |
232 |
$28K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
282 |
250 |
$28K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,459 |
1,191 |
$28K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,370 |
1,227 |
$26K |
| 82553 |
|
5,527 |
4,113 |
$23K |
| 82728 |
|
1,188 |
1,023 |
$23K |
| 88142 |
|
1,104 |
1,002 |
$23K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
194 |
145 |
$23K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
76 |
71 |
$21K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,804 |
1,602 |
$21K |
| 81001 |
|
14,502 |
12,353 |
$19K |
| 74018 |
|
483 |
408 |
$19K |
| 84484 |
|
7,616 |
5,372 |
$19K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
781 |
250 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,630 |
8,010 |
$18K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
894 |
719 |
$18K |
| 96367 |
|
432 |
321 |
$17K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
226 |
207 |
$17K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
383 |
355 |
$15K |
| 83874 |
|
5,766 |
4,290 |
$14K |
| 87480 |
|
917 |
736 |
$14K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,241 |
1,983 |
$14K |
| 84702 |
|
657 |
436 |
$14K |
| 72100 |
|
534 |
457 |
$13K |
| 73562 |
|
553 |
402 |
$13K |
| 71045 |
Radiologic examination, chest; single view |
5,005 |
4,226 |
$12K |
| 83970 |
|
736 |
682 |
$12K |
| 86850 |
|
494 |
398 |
$12K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
695 |
508 |
$11K |
| 83540 |
|
1,027 |
891 |
$11K |
| 73630 |
|
588 |
486 |
$11K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
112 |
67 |
$11K |
| 73610 |
|
484 |
398 |
$10K |
| 84481 |
|
782 |
702 |
$10K |
| 87077 |
|
1,191 |
929 |
$10K |
| J3490 |
Unclassified drugs |
3,073 |
1,897 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
982 |
808 |
$9K |
| 86592 |
|
334 |
304 |
$9K |
| 87660 |
|
843 |
670 |
$9K |
| 84425 |
|
1,057 |
949 |
$9K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
66 |
50 |
$9K |
| 82746 |
|
856 |
739 |
$9K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
508 |
455 |
$8K |
| 87510 |
|
915 |
736 |
$8K |
| 73030 |
|
349 |
279 |
$8K |
| 64493 |
|
15 |
13 |
$8K |
| 86140 |
|
562 |
457 |
$8K |
| 73130 |
|
459 |
367 |
$8K |
| 71250 |
|
77 |
67 |
$8K |
| 0002A |
|
202 |
200 |
$8K |
| 82570 |
|
991 |
846 |
$8K |
| 86900 |
|
542 |
432 |
$7K |
| 97165 |
|
74 |
58 |
$7K |
| 0001A |
|
206 |
200 |
$7K |
| 94060 |
|
56 |
50 |
$7K |
| 86803 |
|
577 |
510 |
$7K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
492 |
374 |
$7K |
| 83735 |
|
2,601 |
2,039 |
$7K |
| 86787 |
|
199 |
181 |
$6K |
| 85027 |
|
719 |
634 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,489 |
6,280 |
$5K |
| 87186 |
|
1,187 |
930 |
$5K |
| 87481 |
|
239 |
232 |
$5K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
321 |
310 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
383 |
355 |
$5K |
| 87147 |
|
611 |
509 |
$5K |
| 84466 |
|
507 |
428 |
$5K |
| 73110 |
|
236 |
201 |
$5K |
| 87653 |
|
104 |
85 |
$4K |
| 83013 |
|
104 |
88 |
$4K |
| 92523 |
|
50 |
38 |
$4K |
| 97035 |
|
67 |
26 |
$4K |
| 80081 |
|
119 |
105 |
$4K |
| 83690 |
|
7,346 |
6,056 |
$4K |
| 97113 |
|
45 |
15 |
$3K |
| 97010 |
|
119 |
43 |
$3K |
| 82043 |
|
747 |
675 |
$3K |
| 84703 |
|
5,929 |
4,880 |
$3K |
| 85610 |
|
1,928 |
1,534 |
$3K |
| 83550 |
|
344 |
309 |
$3K |
| 84153 |
|
206 |
180 |
$3K |
| 86901 |
|
542 |
432 |
$3K |
| 84403 |
|
148 |
131 |
$3K |
| 83525 |
|
108 |
96 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,897 |
7,195 |
$3K |
| 84100 |
|
528 |
414 |
$3K |
| 82950 |
|
203 |
168 |
$3K |
| 87081 |
|
341 |
292 |
$3K |
| 72040 |
|
90 |
80 |
$3K |
| 82947 |
|
3,827 |
3,498 |
$3K |
| 85652 |
|
572 |
461 |
$2K |
| 82550 |
|
5,828 |
4,329 |
$2K |
| 94729 |
|
31 |
25 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
21 |
16 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
24 |
12 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,112 |
904 |
$2K |
| 87505 |
|
20 |
13 |
$2K |
| 82565 |
|
3,907 |
3,540 |
$2K |
| 83001 |
|
79 |
69 |
$2K |
| 73502 |
|
110 |
99 |
$2K |
| 64615 |
|
38 |
37 |
$2K |
| 83880 |
|
695 |
559 |
$2K |
| 87486 |
|
1,061 |
885 |
$2K |
| 93971 |
|
17 |
13 |
$2K |
| 80051 |
|
3,627 |
3,334 |
$2K |
| 86038 |
|
76 |
64 |
$2K |
| 84146 |
|
86 |
72 |
$1K |
| 94726 |
|
20 |
14 |
$1K |
| S9446 |
Patient education, not otherwise classified, non-physician provider, group, per session |
25 |
25 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
11,035 |
8,730 |
$1K |
| 20552 |
|
13 |
12 |
$1K |
| 87581 |
|
1,063 |
886 |
$1K |
| 82948 |
|
1,506 |
780 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,288 |
2,464 |
$1K |
| 77080 |
|
13 |
13 |
$1K |
| 96376 |
|
1,268 |
616 |
$1K |
| 83605 |
|
1,179 |
770 |
$1K |
| 82150 |
|
1,217 |
1,037 |
$1K |
| 85730 |
|
1,441 |
1,217 |
$985.73 |
| 87205 |
|
259 |
209 |
$864.57 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
57 |
51 |
$807.99 |
| 72110 |
|
30 |
25 |
$803.10 |
| 87340 |
|
71 |
68 |
$779.45 |
| 83014 |
|
104 |
88 |
$756.73 |
| 84520 |
|
3,791 |
3,474 |
$751.36 |
| 85379 |
|
1,185 |
929 |
$733.89 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,298 |
2,395 |
$711.20 |
| 84156 |
|
170 |
113 |
$711.06 |
| 82077 |
|
627 |
465 |
$676.02 |
| 87040 |
|
477 |
195 |
$657.32 |
| 87109 |
|
24 |
24 |
$650.34 |
| 83615 |
|
141 |
89 |
$645.56 |
| 73080 |
|
33 |
24 |
$592.73 |
| 87088 |
|
308 |
283 |
$579.13 |
| 80349 |
|
68 |
56 |
$556.12 |
| 82248 |
|
54 |
39 |
$543.52 |
| 84550 |
|
75 |
65 |
$502.18 |
| 80143 |
|
449 |
346 |
$492.17 |
| Q3014 |
Telehealth originating site facility fee |
26 |
23 |
$461.42 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,011 |
553 |
$412.44 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,994 |
4,920 |
$406.06 |
| 82670 |
|
12 |
12 |
$397.73 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,027 |
2,266 |
$382.77 |
| 90715 |
|
23 |
16 |
$370.29 |
| 86696 |
|
15 |
12 |
$346.64 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,113 |
817 |
$346.23 |
| 84436 |
|
31 |
24 |
$339.83 |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,577 |
1,319 |
$320.56 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,805 |
5,992 |
$319.75 |
| 83002 |
|
13 |
13 |
$252.43 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
118 |
93 |
$232.83 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,323 |
799 |
$225.97 |
| 86481 |
|
12 |
12 |
$207.54 |
| 86706 |
|
13 |
12 |
$167.95 |
| 80179 |
|
419 |
324 |
$166.94 |
| 74022 |
|
32 |
28 |
$163.47 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
930 |
792 |
$106.80 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
815 |
418 |
$102.68 |
| J1815 |
Injection, insulin, per 5 units |
125 |
40 |
$100.40 |
| 80321 |
|
53 |
49 |
$97.96 |
| 84145 |
|
89 |
57 |
$96.58 |
| J2704 |
Injection, propofol, 10 mg |
1,986 |
1,606 |
$80.41 |
| 94761 |
|
2,552 |
1,858 |
$67.83 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,606 |
1,924 |
$66.57 |
| C9113 |
Injection, pantoprazole sodium, per vial |
80 |
39 |
$64.51 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,826 |
1,370 |
$48.10 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
537 |
384 |
$38.63 |
| J7999 |
Compounded drug, not otherwise classified |
34 |
17 |
$36.33 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
175 |
125 |
$32.10 |
| 82803 |
|
13 |
12 |
$28.11 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
280 |
216 |
$28.08 |
| 84450 |
|
33 |
29 |
$26.90 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
778 |
470 |
$26.43 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
110 |
76 |
$21.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
87 |
67 |
$18.01 |
| 84460 |
|
33 |
29 |
$17.94 |
| J1644 |
Injection, heparin sodium, per 1000 units |
82 |
28 |
$15.87 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,694 |
1,029 |
$13.91 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
293 |
196 |
$10.57 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
129 |
111 |
$8.72 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
31 |
26 |
$7.72 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
102 |
83 |
$7.20 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
370 |
320 |
$4.75 |
| 91300 |
|
390 |
312 |
$3.84 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
100 |
92 |
$3.15 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
23 |
12 |
$3.13 |
| J2060 |
Injection, lorazepam, 2 mg |
58 |
36 |
$2.09 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
38 |
31 |
$1.51 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
41 |
25 |
$1.20 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
43 |
27 |
$1.19 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
17 |
13 |
$0.55 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
16 |
12 |
$0.22 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
33 |
27 |
$0.00 |
| 82310 |
|
25 |
24 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
348 |
245 |
$0.00 |
| J2253 |
Injection, midazolam (seizalam), 1 mg |
49 |
48 |
$0.00 |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
45 |
15 |
$0.00 |
| 94760 |
|
487 |
340 |
$0.00 |
| 88304 |
|
23 |
13 |
$0.00 |
| 87807 |
|
29 |
29 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
23 |
16 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
94 |
72 |
$0.00 |